183 results
8-K
EX-10.1
MBOT
Microbot Medical Inc
30 Jan 24
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
7:20am
8-K
EX-10.2
MBOT
Microbot Medical Inc
30 Jan 24
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
7:20am
S-1/A
EX-10.32
MBOT
Microbot Medical Inc
IPO registration (amended)
22 Jan 24
5:20pm
8-K
EX-10.1
MBOT
Microbot Medical Inc
2 Jan 24
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
MBOT
Microbot Medical Inc
21 Nov 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-10.1
9lgod
28 Jun 23
Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
6:13pm
8-K
EX-10.1
ey3 kvulm9
6 Jun 23
Entry into a Material Definitive Agreement
5:03pm
8-K
EX-10.2
tdvzov l2
24 May 23
Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:32pm
8-K
EX-10.1
4uf66plbibwht
24 May 23
Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:32pm
8-K
EX-10.1
wvc5f
23 May 23
Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-10.2
yztl3
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
EX-10.1
0du6g1i
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
EX-10.4
imf63xpbvg8 9r3o
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
EX-10.3
bf0ai
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
EX-10.1
73jiq
25 Oct 22
Microbot Medical Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:00pm
8-K
EX-10.1
rjirv ooa
7 Oct 22
Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices
8:59am
8-K
EX-10.1
o43nw
6 Apr 22
Microbot Medical Continues to Strengthen Management Team as Rachel Vaknin Promoted to Chief Financial Officer
4:05pm
8-K
EX-10.1
r5v2 rak17hbuy
1 Feb 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
0i99b1rjlhhmdxyzg
27 Dec 21
Microbot Medical Announces Strategic Collaboration with Stryker Corporation to Develop the LIBERTY® Robotic System for Neurovascular Applications
7:05am